Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:33 pm Sale | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | First Light Asset Management, LLC | 769,117 5.340% | -117,914![]() (-13.29%) | Filing History |
| 2026-08-14 4:18 pm Sale | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 672,789 4.700% | -206,220![]() (-23.46%) | Filing History |
| 2026-08-10 2:12 pm Purchase | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | PRUDENTIAL FINANCIAL INC PRU | 962,374 6.700% | 962,374![]() (New Position) | Filing History |
| 2026-08-03 10:48 am Purchase | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | Jennison Associates LLC | 960,619 6.700% | 960,619![]() (New Position) | Filing History |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | BlackRock, Inc. BLK | 812,953 5.700% | 796,672![]() (+4893.26%) | Filing History |
| 2026-02-17 4:34 pm Purchase | 2025-12-31 | 13G | PALVELLA THERAPEUTICS INC PVLA | First Light Asset Management, LLC | 887,031 7.490% | 887,031![]() (New Position) | Filing History |
| 2026-02-17 4:21 pm Sale | 2025-12-31 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 879,009 7.100% | -302,185![]() (-25.58%) | Filing History |
| 2026-02-13 5:33 pm Purchase | 2025-12-31 | 13G | PALVELLA THERAPEUTICS INC PVLA | Frazier Life Sciences Public Fund, L.P. | 706,360 6.000% | 160,856![]() (+29.49%) | Filing History |
| 2025-11-14 4:19 pm Purchase | 2025-09-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 1,181,194 9.990% | 13,077![]() (+1.12%) | Filing History |
| 2025-11-13 5:31 pm Purchase | 2025-09-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | Montanova Capital, LLC | 822,400 7.400% | 107,937![]() (+15.11%) | Filing History |
| 2025-08-14 5:26 pm Sale | 2025-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | Samsara BioCapital, L.P. | 339,743 3.100% | -339,743![]() (-50.00%) | Filing History |
| 2025-08-14 1:41 pm Sale | 2025-06-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | Frazier Life Sciences Public Fund, L.P. | 545,504 4.900% | -144,508![]() (-20.94%) | Filing History |
| 2025-05-15 09:39 am Purchase | 2025-03-31 | 13G | PALVELLA THERAPEUTICS INC PVLA | Frazier Life Sciences Public Fund, L.P. | 690,012 6.300% | 114,120![]() (+19.82%) | Filing History |
| 2025-01-08 3:04 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | Frazier Life Sciences Public Fund, L.P. | 575,892 5.100% | 575,892![]() (New Position) | Filing History |
| 2024-12-20 5:32 pm Purchase | 2024-12-13 | 13D | PALVELLA THERAPEUTICS INC PVLA | Kaupinen Wes | 1,644,869 14.600% | 1,644,869![]() (New Position) | Filing History |
| 2024-12-20 4:59 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | Samsara BioCapital, L.P. | 679,486 6.100% | 679,486![]() (New Position) | Filing History |
| 2024-12-20 4:56 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | Montanova Capital, LLC | 714,463 8.600% | 714,463![]() (New Position) | Filing History |
| 2024-12-17 5:42 pm Purchase | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 1,168,117 9.990% | 910,495![]() (+353.42%) | Filing History |
| 2024-12-17 4:22 pm Unchanged | 2024-12-13 | 13G | PALVELLA THERAPEUTICS INC PVLA | Dellora Investments Master Fund LP | 141,079 1.300% | 0 (Unchanged) | Filing History |
| 2024-12-06 2:21 pm Purchase | 2024-11-06 | 13G | PIERIS PHARMACEUTICALS INC PIRS | Dellora Investments Master Fund LP | 141,079 10.700% | 32,105![]() (+29.46%) | Filing History |

